US Stock MarketDetailed Quotes

KAPA Kairos Pharma

Watchlist
  • 1.650
  • -0.050-2.94%
Close Nov 27 16:00 ET
  • 1.590
  • -0.060-3.64%
Post 20:01 ET
21.20MMarket Cap-7857P/E (TTM)

Kairos Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
33.45%383K
4.72%222K
127.78%287K
200.18%1.71M
505.00%1.09M
131.45%287K
76.67%212K
-14.29%126K
-70.61%571K
180K
Selling and administrative expenses
53.74%329K
-12.50%119K
2.50%82K
354.32%1.47M
1,032.61%1.04M
154.76%214K
83.78%136K
8.11%80K
-80.51%324K
--92K
-General and administrative expense
53.74%329K
-12.50%119K
2.50%82K
354.32%1.47M
1,032.61%1.04M
154.76%214K
83.78%136K
8.11%80K
-80.51%324K
--92K
Research and development costs
-57.58%14K
75.00%63K
2,650.00%165K
-5.75%82K
-85.42%7K
--33K
500.00%36K
-81.82%6K
-52.46%87K
--48K
Depreciation amortization depletion
0.00%40K
0.00%40K
0.00%40K
0.00%160K
0.00%40K
0.00%40K
0.00%40K
0.00%40K
63.27%160K
--40K
-Depreciation and amortization
0.00%40K
0.00%40K
0.00%40K
0.00%160K
0.00%40K
0.00%40K
0.00%40K
0.00%40K
63.27%160K
--40K
Operating profit
-33.45%-383K
-4.72%-222K
-127.78%-287K
-200.18%-1.71M
-505.00%-1.09M
-131.45%-287K
-76.67%-212K
14.29%-126K
70.61%-571K
-180K
Net non-operating interest income expense
-2,556.00%-664K
-29.17%-31K
-80.00%-36K
79.54%-98K
-81.25%-29K
77.27%-25K
90.94%-24K
77.27%-20K
-137.13%-479K
-16K
Non-operating interest expense
408.00%127K
29.17%31K
80.00%36K
-78.65%98K
81.25%29K
-77.27%25K
-90.94%24K
-70.59%20K
179.88%459K
--16K
Total other finance cost
--537K
----
----
----
----
----
----
----
-47.37%20K
--0
Other net income (expense)
Income before tax
-235.58%-1.05M
-7.20%-253K
-121.23%-323K
-72.57%-1.81M
-470.41%-1.12M
-33.33%-312K
38.70%-236K
37.87%-146K
51.05%-1.05M
-196K
Income tax
Net income
-235.58%-1.05M
-7.20%-253K
-121.23%-323K
-72.57%-1.81M
-470.41%-1.12M
-33.33%-312K
38.70%-236K
37.87%-146K
51.05%-1.05M
-196K
Net income continuous Operations
-235.58%-1.05M
-7.20%-253K
-121.23%-323K
-72.57%-1.81M
-470.41%-1.12M
-33.33%-312K
38.70%-236K
37.87%-146K
51.05%-1.05M
---196K
Minority interest income
Net income attributable to the parent company
-235.58%-1.05M
-7.20%-253K
-121.23%-323K
-72.57%-1.81M
-470.41%-1.12M
-33.33%-312K
38.70%-236K
37.87%-146K
51.05%-1.05M
-196K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-235.58%-1.05M
-7.20%-253K
-121.23%-323K
-72.57%-1.81M
-470.41%-1.12M
-33.33%-312K
38.70%-236K
37.87%-146K
51.05%-1.05M
-196K
Basic earnings per share
-259.48%-0.1
0.00%-0.02
-200.00%-0.03
-70.00%-0.17
-353.20%-0.0997
-30.15%-0.0278
41.74%-0.02
52.27%-0.01
0.00%-0.1
-0.022
Diluted earnings per share
-259.48%-0.1
0.00%-0.02
-200.00%-0.03
-70.00%-0.17
-353.20%-0.0997
-30.15%-0.0278
41.74%-0.02
52.27%-0.01
0.00%-0.1
-0.022
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 33.45%383K4.72%222K127.78%287K200.18%1.71M505.00%1.09M131.45%287K76.67%212K-14.29%126K-70.61%571K180K
Selling and administrative expenses 53.74%329K-12.50%119K2.50%82K354.32%1.47M1,032.61%1.04M154.76%214K83.78%136K8.11%80K-80.51%324K--92K
-General and administrative expense 53.74%329K-12.50%119K2.50%82K354.32%1.47M1,032.61%1.04M154.76%214K83.78%136K8.11%80K-80.51%324K--92K
Research and development costs -57.58%14K75.00%63K2,650.00%165K-5.75%82K-85.42%7K--33K500.00%36K-81.82%6K-52.46%87K--48K
Depreciation amortization depletion 0.00%40K0.00%40K0.00%40K0.00%160K0.00%40K0.00%40K0.00%40K0.00%40K63.27%160K--40K
-Depreciation and amortization 0.00%40K0.00%40K0.00%40K0.00%160K0.00%40K0.00%40K0.00%40K0.00%40K63.27%160K--40K
Operating profit -33.45%-383K-4.72%-222K-127.78%-287K-200.18%-1.71M-505.00%-1.09M-131.45%-287K-76.67%-212K14.29%-126K70.61%-571K-180K
Net non-operating interest income expense -2,556.00%-664K-29.17%-31K-80.00%-36K79.54%-98K-81.25%-29K77.27%-25K90.94%-24K77.27%-20K-137.13%-479K-16K
Non-operating interest expense 408.00%127K29.17%31K80.00%36K-78.65%98K81.25%29K-77.27%25K-90.94%24K-70.59%20K179.88%459K--16K
Total other finance cost --537K-----------------------------47.37%20K--0
Other net income (expense)
Income before tax -235.58%-1.05M-7.20%-253K-121.23%-323K-72.57%-1.81M-470.41%-1.12M-33.33%-312K38.70%-236K37.87%-146K51.05%-1.05M-196K
Income tax
Net income -235.58%-1.05M-7.20%-253K-121.23%-323K-72.57%-1.81M-470.41%-1.12M-33.33%-312K38.70%-236K37.87%-146K51.05%-1.05M-196K
Net income continuous Operations -235.58%-1.05M-7.20%-253K-121.23%-323K-72.57%-1.81M-470.41%-1.12M-33.33%-312K38.70%-236K37.87%-146K51.05%-1.05M---196K
Minority interest income
Net income attributable to the parent company -235.58%-1.05M-7.20%-253K-121.23%-323K-72.57%-1.81M-470.41%-1.12M-33.33%-312K38.70%-236K37.87%-146K51.05%-1.05M-196K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -235.58%-1.05M-7.20%-253K-121.23%-323K-72.57%-1.81M-470.41%-1.12M-33.33%-312K38.70%-236K37.87%-146K51.05%-1.05M-196K
Basic earnings per share -259.48%-0.10.00%-0.02-200.00%-0.03-70.00%-0.17-353.20%-0.0997-30.15%-0.027841.74%-0.0252.27%-0.010.00%-0.1-0.022
Diluted earnings per share -259.48%-0.10.00%-0.02-200.00%-0.03-70.00%-0.17-353.20%-0.0997-30.15%-0.027841.74%-0.0252.27%-0.010.00%-0.1-0.022
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday-1.11%